Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
18.2M
-
Shares change
-
-694K
-
Total reported value, excl. options
-
$42.6M
-
Value change
-
-$5.35M
-
Put/Call ratio
-
0.03
-
Number of buys
-
24
-
Number of sells
-
-22
-
Price
-
$2.34
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q4 2022
62 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q4 2022.
Apyx Medical Corp - Common Stock (APYX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.2M shares
of 35M outstanding shares and own 52.02% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.45M shares), RTW INVESTMENTS, LP (3.4M shares), COWEN AND COMPANY, LLC (1.78M shares), VANGUARD GROUP INC (1.41M shares), BARCLAYS PLC (842K shares), ROYCE & ASSOCIATES LP (798K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), PURA VIDA INVESTMENTS, LLC (608K shares), Cowen Prime Advisors LLC (606K shares), and BlackRock Inc. (523K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.